Bone Biologics Corp [NASDAQ: BBLG] surged by $39345.84 during the normal trading session on Friday and reaching a high of $6.19 during the day while it closed the day at $39350.0.
Bone Biologics Corp stock has also loss -22.50% of its value over the past 7 days. However, BBLG stock has declined by -9.32% in the 3 months of the year. Over the past six months meanwhile, it has lost -22.76% and lost -36.91% year-on date.
The market cap for BBLG stock reached $2.50 million, with 0.55 million shares outstanding and 0.54 million shares in the current float. Compared to the average trading volume of 39.35K shares, BBLG reached a trading volume of 26568505 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Bone Biologics Corp [BBLG]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BBLG shares is $22.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BBLG stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.86, with the Price to Cash per share for the same quarter was set at 5.04.
BBLG stock trade performance evaluation
Bone Biologics Corp [BBLG] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -22.50. With this latest performance, BBLG shares dropped by -8.51% in over the last four-week period, additionally sinking by -22.76% over the last 6 months – not to mention a drop of -18.82% in the past year of trading.
Bone Biologics Corp [BBLG]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -121.79%, with Return on Assets sitting at -121.79%.
Earnings per share (EPS) analysis for Bone Biologics Corp [BBLG] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BBLG. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bone Biologics Corp go to 79.61%.
Bone Biologics Corp [BBLG]: Institutional Ownership
There are presently around $1.10%, or 1.10% of BBLG stock, in the hands of institutional investors. The top three institutional holders of BBLG stocks are: UBS GROUP AG with ownership of 33707.0 shares, which is approximately 5.1%. HRT FINANCIAL LP, holding 17519.0 shares of the stock with an approximate value of $$21000.0 in BBLG stocks shares; and HRT FINANCIAL LP, currently with $$7063.0 in BBLG stock with ownership which is approximately 0.8759%.
